Private Equity firm leading and managing investments in healthcare and technology, averaging more than 45% cash on cash returns since inception.

Provide strategic insight to assist Glenview Capital in managing their oncology investments.

A Gibson Investment Group, INC portfolio company serving Patients, Physicians and Hospitals in Oklahoma. Acquired in 2007 through a UCC Article 9 Sale from Bridge Healthcare Finance. Transformed and expanded a distressed Oncology Practice into a statewide Multispecialty Group sold to McKesson / US Oncology in 2014Acquired and transformed an oncology practice into a multispecialty group in response to healthcare reform. Leveraged strategy operations and technology expertise to generate more than a 10x cash on cash returnConceived and researched a business plan to acquire and operate cancer centers. Perfomed a national search for acquisition targets that yielded a turnaround opportunity in Oklahoma nearing foreclosureContracted with lender to manage the foreclosed centers. In the first six months increased EBITDA by $3 Million; formed a JV with the Physician Group to acquire the facilities; and purchased the assets of the centers through a UCC Article 9 saleReengineered clinical processes using more than $10 Million in new equipment and software including EMRGrew revenue from $20 Million to $25 million adding two additional radiation therapy centers and developing oncology service offerings for Hospitals and other providersDeveloped and implemented a multispecialty group practice model in response to healthcare reformIncreased revenue from $25 million to $35 million through the addition of 13 specialists to form Oklahoma Multispecialty GroupDeveloped and implemented a stark-compliant physician compensation model for ancillary servicesRestructured pathology lab based on reductions in CMS reimbursementImplemented Calypso localization technology to enhance patient outcomes and differentiate service offeringDeveloped, implemented a transparent bundled pricing model for self-insured employers Lead the process to identify a strategic buyer that could add value to patients, physcians and employees. Sold the practice to McKesson / US Oncology in August of 2014

Identified, negotiated, and acquired a radiation oncology center in Riverside, CA utilizing an owner-financed leveraged buy-out.Delivered 45% annual ROI by applying operations and business development experience.

Co-Founder of Deloitte Ventures first investment, a multinational CRM joint venture for Deloitte and WPP Group, PLC generating more than $75M in annual revenue and operating with 250 professionals in North America and Europe. Managed geographic operations and business development. Drove sales and streamlined operations year-over-year. Expanded annual revenue to $75M while producing more than $100M in pull-through revenue for Deloitte. Implemented an account management program leading to dramatic increases in revenue per account from $250K to over $2M. Architected and implemented a project portfolio management system that reduced risk, DSO, and increase average realization by 22%. Decreased overall costs by more than 43%.

Consulting Principal responsible for developing and managing client relationships and service lines including: Workflow & Content Management & CRM

Held direct responsibility for western one-third of US operations. Partnered with major CRM Software Vendors.Combined Deloitte industry principals with software business development resources to increase service revenue by more than $60 million within first 12 months.

Bootstrapped the global workflow and content management practice.Developed allianaces with major software vendors.Assisted with the development of Deloitte software and hardware resale group.Grew service line revenue to more than $50M in annual revenue.

Co-developed a statewide systems integration practice in California. Help recruit and hire personnel growing staff from 5 to over 250. Contributed to the development of a $100M practice over three-year period.

Managed Strategic Client Relationships

R&D, Marketing, Sales of New Document Imaging Solutions including OS/2 Image Plus